CERS6 and acute lymphoblastic leukemia: To determine whether higher levels of CERS6 in ALL contributes to resistance in cytotoxicity of chemotherapeutic drugs, we carried out loss-of-function (knockdown of CERS6) and gain-of-function (CERS6 overexpression) experiments in ALL cells.